Lincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share for the financial year, following its board meeting on May 28, 2026. The announcement was made through NSE corporate filings.
Lincoln Pharmaceuticals Board has recommended a final dividend of Rs 1.80 per equity share for FY26, following its May 28, 2026 meeting. The proposal awaits shareholder approval.
Lincoln Pharmaceuticals Board recommends final dividend of Rs 1.80 per equity share following May 28, 2026 board meeting for shareholder approval.
Lincoln Pharmaceuticals Limited's board has recommended a final dividend of Rs 1.80 per equity share following its meeting on May 28, 2026.
Lincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share following its May 28, 2026 board meeting, subject to shareholder clearance.
Lincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share (18%) for FY2026, subject to approval at the upcoming Annual General Meeting.
Lincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share for FY26, representing an 18% return on the Rs 10 face value.
Lincoln Pharmaceuticals has proposed a final dividend of Rs 1.80 per equity share (18%) for the financial year ended March 31, 2026, awaiting shareholder approval at the ensuing AGM.
Lincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share (18%) for the financial year ended March 31, 2026.
Lincoln Pharmaceuticals has filed its Q4 FY2026 financial results with the NSE, concluding the fiscal year ended March 31, 2026.
LINCOLN PHARMACEUTICALS Q3 FY25 Results
LINCOLN PHARMACEUTICALS Q2 FY25 Results
NSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.
Need more? Pro tracks up to 500 companies with preferential issue alerts.
No credit card required. Connect WhatsApp or Telegram in minutes.